What AI says about Nitto Avecia
Nitto Denko Avecia provides comprehensive oligonucleotide solutions from preclinical manufacturing to drug substance production. Its experts develop and validate safe, robust, and cost-effective processes to advance oligonucleotide programs.
AI named Nitto Avecia from December 2025 to January 2026.